After plunging in after-hours trading Monday, Exact Sciences (NASDAQ: EXAS) issued the following statement following the U.S. Preventive Services Task ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Management Comments Trader Talk

Exact Sciences (EXAS) Drops Another 20%October 8, 2015 11:25 AM Whitney Tilson Says Exact Sciences (EXAS) Still a Great ShortOctober 7, 2015 10:20 AM Mizuho Securities Cuts Price Target on Exact Sciences (EXAS) to $12 Following USPSTF Cologuard Guidelines October 7, 2015 6:50 AM Lake Street Capital Markets Downgrades Exact Sciences (EXAS) to HoldOctober 6, 2015 1:44 PM Exact Sciences (EXAS) PT Lowered to $15 at Roth Capital, Recommends Buying on WeaknessOctober 6, 2015 12:14 PM Exact Sciences (EXAS) PT Slashed to $11 at Goldman Sachs on Negative USPSTF RulingOctober 6, 2015 9:32 AM Canaccord Genuity Reiterates Buy on Exact Sciences (EXAS) Following USPSTF's Draft Recommendation for Colorectal Screening Guidelines October 6, 2015 8:45 AM Benchmark Downgrades Exact Sciences (EXAS) to HoldOctober 6, 2015 8:03 AM USPSTF Draft Recommendation Not as Bullish as Expected for Exact Sciences (EXAS), Wedbush Says; But Would Buy Below $18October 6, 2015 7:25 AM Impact on Exact Sciences (EXAS) from USPSTF Guidlines 'Unclear', Jefferies Says; Would Be Buyers on WeaknessOctober 6, 2015 6:53 AM Cologuard® Included as Alternative Screening Test under Draft USPSTF GuidelinesOctober 5, 2015 8:21 PM After Hours Stocks Movers 10/05: (STRZA) (RGLS) (LGF) Higher; (EXAS) (ILMN) (TCS) (more...)October 5, 2015 6:33 PM Exact Sciences (EXAS) Shares Drop After-HoursOctober 5, 2015 5:45 PM